ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software

Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis...

July 06, 2023 | Thursday | News
Organon & Samsung Bioepis Launch HADLIMA™ Biosimilar of HUMIRA in the US

Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program “HADLIMA For You” ...

July 03, 2023 | Monday | News
Biogen's New Data Highlights SPINRAZA® Benefit in Infants and Toddlers after Gene Therapy

Interim results from the RESPOND study show improved motor function in most participants treated with SPINRAZA after Zolgensma® (onasemnogene abeparv...

July 03, 2023 | Monday | News
Sandoz Launches Hyrimoz® High-Concentration Formulation in US Immunology Space

Hyrimoz® (adalimumab-adaz) high-concentration formulation (HCF) biosimilar offers US patients reduced injection volume in citrate-free formulation A...

July 03, 2023 | Monday | News
Bionano Announces the Stratys™ System for OGM and VIA™ Software for Hematologic Malignancies

The Stratys™ instrument for optical genome mapping (OGM) will enable a four-fold increase in raw data generation rate compared to the Saphyr® i...

June 30, 2023 | Friday | News
Celmatix Announces Breakthrough in Novel Oral Fertility Drug Program

-Celmatix Inc., the leading women’s health biotechnology company focused on ovarian biology, today announced the identification of promising early le...

June 29, 2023 | Thursday | News
Bayer initiates Phase III studies with investigational contrast agent gadoquatrane

Gadoquatrane is a highly stable contrast agent for magnetic resonance imaging (MRI) with high relaxivity and the potential of a substantially lower gadol...

June 28, 2023 | Wednesday | News
Theriva Biologics Receives FDA Orphan Drug Designation for VCN-01 in Pancreatic Cancer Treatment

In VIRAGE, the ongoing multinational Phase 2b clinical study, intravenous VCN-01 is being evaluated in combination with standard-of-care (SoC) chemotherapy...

June 28, 2023 | Wednesday | News
Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET™ technology

By using this cutting-edge imaging technology in preclinical studies, Oncodesign Services’ team hopes to gain insights of the predictive effectivenes...

June 28, 2023 | Wednesday | News
Enveric Biosciences Advances EB-373 with Phase 1 Formulation and Manufacturing Initiation.

Enveric to expand existing manufacturing agreement with CDMO partner for enhanced supply of non-GMP and GMP EB-373 drug substance Enveric Biosciences (NAS...

June 27, 2023 | Tuesday | News
Twist Bioscience Publishes Preclinical Data Validating GLP-1R Antagonist Antibody for Congenital Hyperinsulinism Treatment.

-Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

June 27, 2023 | Tuesday | News
AI-Based Health Screening Company iHealthScreen Reaches $150K in Investments

AI-based health screening company iHealthScreen recently announced raising $150,000 in investments on StartEngine. To date, the company has raised $3 milli...

June 27, 2023 | Tuesday | News
Stanford University and Intonation Research Labs Collaborate to Combat Neuroendocrine Tumors

he goal of the collaboration is to reduce the time and resources it takes to translate a biomedical breakthrough into a clinically and commercially viable ...

June 23, 2023 | Friday | News
Spaulding Clinical Expands Services to Include ADME Clinical Trials

ADME studies are vital components of drug development, providing critical insights into the behavior of drugs within the human body. By measuring the absor...

June 23, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close